The association between BMI, smoking, drinking and thyroid disease: a cross-sectional study in Wuhan, China

BMC Endocrine Disorders

Table 3 Associations of SHO with BMI and smoking in subgroups stratified by other variables

Subgroup	N	BMI ≥ 25 kg/m²				Smoker
Subgroup	N	n	OR	95 %CI	P value	n	OR	95 %CI	P value
Sex^a
Male	46	28	1.770	0.945–3.315	0.074	29	0.896	0.470–1.709	0.739
Female	148	60	1.464	0.990–2.164	0.056	9	1.352	0.605–3.023	0.463
Age (years)^b
≤ 40	66	24	1.562	0.880–2.773	0.128	15	1.045	0.459–2.381	0.916
40–60	94	41	1.368	0.850–2.202	0.197	18	1.293	0.574–2.914	0.536
> 60	34	23	2.075	0.939–4.585	0.071	5	0.678	0.199–2.308	0.535
Antibody^c
Antibody -	134	57	1.436	0.976–2.114	0.066	26	0.763	0.419–1.389	0.376
Antibody +	60	31	2.221	1.168–4.184	0.015	12	2.757	0.909–8.359	0.073
Smoker^d
No	156	24	1.443	0.994–2.096	0.054	0	N/A
Yes	38	64	2.179	1.041–4.561	0.039	38	N/A
BMI (kg/m²)^e
< 25	106	0	N/A			24	0.833	0.382–1.816	0.645
≥ 25	88	88	N/A			14	1.224	0.597–2.512	0.581

Abbreviations: BMI body mass index, Antibody + (positive) for at least one thyroid antibody, Antibody - negative for both thyroid antibodies. All the variables were analysed by multivariate logistic regression: ^a Adjusted for age, antibody, smoking, and BMI. ^b Adjusted for sex, antibody, smoking, and BMI. ^c Adjusted for sex, age, smoking, and BMI. ^d Adjusted for sex, age, antibody, and BMI. ^e Adjusted for sex, age, antibody, and smoking

ISSN: 1472-6823